Three startups awarded $20K in Paratus Digital Health Accelerator final showcase

Ad Astra Diagnostics, Omphalos Lifesciences and Shaddari Inc. have each been awarded $20,000 following Paratus Digital Health Accelerator’s final showcase.

The three startups — part of the first two cohorts of the Paratus Digital Health Accelerator — were selected for pioneering digital health solutions to support public health preparedness. Each cohort participated in a 10-week virtual accelerator and received mentorship, exclusive resources and curriculum from subject matter experts. Both programs concluded with a virtual showcase on September 9.

The three prize winners were recognized for the strength of their innovative solutions and pitches:

Ad Astra Diagnostics, Inc. — Morrisville, North Carolina
Ad Astra Diagnostics, Inc. provides rapid patient-side diagnostics on a digital platform to enable fast health decisions that save time, save money and save lives.

Omphalos Lifesciences — Dallas, Texas
Omphalos Lifesciences is creating AI Virtual Cell technology to power predictive, programmable modeling of living systems — laying the foundation for advanced research, targeted therapies and precision care.

Shaddari Inc. — Montreal, Canada
Shaddari has transformed how vaccines, antibody drugs and biologics are tested against mutations. Their digital solution provides instant results for faster decision making during viral outbreaks or cancer treatments, ensuring treatments stay effective against mutations while saving time and reducing costs.

To learn more about the Paratus Digital Health Accelerator and current opportunities, visit matter.health/paratus.

This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under agreement number 75A50124C00028.